PMID- 37364698 OWN - NLM STAT- MEDLINE DCOM- 20230714 LR - 20230718 IS - 1879-0038 (Electronic) IS - 0378-1119 (Linking) VI - 878 DP - 2023 Aug 20 TI - Association between GLP-1R gene polymorphism and dyslipidemia in Chinese patients with type 2 diabetes mellitus: A case-control study. PG - 147589 LID - S0378-1119(23)00430-4 [pii] LID - 10.1016/j.gene.2023.147589 [doi] AB - OBJECTIVE: To evaluate the relationship between GLP-1R gene polymorphisms and type 2 diabetes mellitus with dyslipidemia and without dyslipidemia in China. METHODS: A total of 200 patients with Type 2 Diabetes Mellitus (T2DM) were included in this study, including 115 with dyslipidemia and 85 without dyslipidemia. We used Sanger double deoxygenation terminal assay and PCR-RFLP to detect genotype of the GLP-1R rs10305420 and rs3765467 loci. T-test was used to analyze the association between gene polymorphisms and lipid indicators. SHEsis online analysis software was used to analyze the linkage balance effect of loci, and SPSS 26 was used to calculate the gene interaction by dominant model. RESULTS: The genotype distribution of the two loci in the sample of this study was in accordance with Hardy-weinberg equilibrium. There were significant differences in the genotype distribution and allele frequency of rs3765467 between T2DM patients with and without dyslipidemia (GG 52.9%, GA + AA 47.1% vs. GG 69.6%, GA + AA 30.4%; P = 0.017). Under the dominant model, the effects of rs3765467 A allele and rs10305420 T allele on dyslipidemia had multiplicative interactions (P = 0.016) and additive interactions (RERI = 0.403, 95% CI [-2.708 to 3.514]; AP = 0.376, 95% CI [-2.041, 2.793]). Meanwhile, HbA(1c) levels in rs3765467 A allele carriers (GA + AA) were found to be significantly lower than those in patients with GG genotype (P = 0.006). CONCLUSION: The rs3765467 (G/A) variant is associated with the incidence of dyslipidemia, and G allele may be a risk factor for dyslipidemia. CI - Copyright (c) 2023 The Authors. Published by Elsevier B.V. All rights reserved. FAU - Li, Yue AU - Li Y AD - Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University & Shandong 6 Provincial Qianfoshan Hospital, Jinan, Shandong, China. Electronic address: jiduoxintiao110@163.com. FAU - Yang, Zhiyan AU - Yang Z AD - Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University & Shandong 6 Provincial Qianfoshan Hospital, Jinan, Shandong, China. Electronic address: yangzhiyan00@163.com. FAU - Ren, Shuyu AU - Ren S AD - Jinan Xinhang Experimental Foreign Language School, Jinan, Shandong, China. Electronic address: 2456493636@qq.com. FAU - Shen, Bowen AU - Shen B AD - Department of Pharmacy, Shandong First Medical University, Taian, Shandong, China. Electronic address: 1565902480@qq.com. FAU - Zhang, Yundi AU - Zhang Y AD - Department of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China. Electronic address: 2216072194@qq.com. FAU - Zong, Huiying AU - Zong H AD - Department of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China. Electronic address: zongzong33@163.com. FAU - Li, Yan AU - Li Y AD - Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University & Shandong 6 Provincial Qianfoshan Hospital, Jinan, Shandong, China. Electronic address: li_xyan@126.com. LA - eng PT - Journal Article DEP - 20230624 PL - Netherlands TA - Gene JT - Gene JID - 7706761 RN - 0 (GLP1R protein, human) RN - 0 (Glucagon-Like Peptide-1 Receptor) SB - IM MH - Humans MH - Case-Control Studies MH - China/epidemiology MH - *Diabetes Mellitus, Type 2/complications/genetics/epidemiology MH - *Dyslipidemias/genetics MH - East Asian People MH - Gene Frequency MH - Genetic Predisposition to Disease MH - Genotype MH - Polymorphism, Single Nucleotide MH - *Glucagon-Like Peptide-1 Receptor/genetics OTO - NOTNLM OT - Dyslipidemia OT - GLP-1R gene OT - Lipid profile OT - Mutation OT - T2DM COIS- Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2023/06/27 01:06 MHDA- 2023/07/14 13:07 CRDT- 2023/06/26 19:20 PHST- 2023/04/26 00:00 [received] PHST- 2023/06/11 00:00 [revised] PHST- 2023/06/21 00:00 [accepted] PHST- 2023/07/14 13:07 [medline] PHST- 2023/06/27 01:06 [pubmed] PHST- 2023/06/26 19:20 [entrez] AID - S0378-1119(23)00430-4 [pii] AID - 10.1016/j.gene.2023.147589 [doi] PST - ppublish SO - Gene. 2023 Aug 20;878:147589. doi: 10.1016/j.gene.2023.147589. Epub 2023 Jun 24.